Great to see you back on BIT threads TP (your posts inspired me to research BIT over 12 months ago).
I'm hoping that the next trial is a HIV/HCV co-infected patient one. My thinking is that the novel ion-channel technology held by BIT needs to be applied across a viral spread rather than focussing on HCV only. This publication (originally posted by Neo) also mentions applicability to SARS.
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0027660
Given drug resistance issues with the new generation drugs for HCV there will always be an opportunity to throw BIT225 into the mix for a shotgun approach to this disease.
Certainly value your input here
bluebush
allotment, page-66
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 2.0¢ | 1.9¢ | $6.369K | 330.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 847148 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1129029 | 5 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| BIT (ASX) Chart |